11. |
Ifosfamide-based regimen in NHL and Hodgkin's disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
12. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
13. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 14-14
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
14. |
'Viramune' hepatic safety study: majority of events asymptomatic |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 15-16
Raewyn Poole,
Preview
|
|
摘要:
The non-nucleoside reverse transcriptase inhibitor (NNRTI) nevirapine ['Viramune'] is not associated with a higher risk of hepatotoxicity than other antiretroviral agents, according to results from Boehringer Ingelheim's Viramune® Hepatic Safety Project presented at the XIV International AIDS Conference [Barcelona, Spain; July 2002]. This analysis of data from controlled and uncontrolled clinical studies and observational cohorts showed that the majority of hepatic adverse events associated with nevirapine were asymptomatic and could be managed by treatment interruption.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
15. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
16. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
17. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
18. |
PRODUCT INTRODUCTIONS |
|
Inpharma Weekly,
Volume &NA;,
Issue 1356,
2002,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|